Try Premium for 30 days

Live games for all NFL, MLB, NBA, & NHL teams
Unlimited Audiobooks
Commercial-Free Music
No Display Ads
DTB podcast-logo

DTB podcast

1 Favorite

More Information

Location:

United Kingdom

Twitter:

@DTB_BMJ

Language:

English


Episodes

November 2017: Prescribing in pregnancy - stop stopping and start planning

11/6/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the challenges associated with prescribing for long-term conditions in women who are pregnant and raise concerns that medicines may be stopped inappropriately. Read the editorial here: http://dtb.bmj.com/content/55/11/121. The editors also review a combination product containing naltrexone and bupropion that is licensed for the management of obesity -...

Duration: 00:14:27


October 2017: Flagging risk

10/9/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the fragmented approach to communicating additional risk minimisation measures for medicines. Article available here: http://dtb.bmj.com/content/55/10/1. The editors also review the long-term safety of PPIs (http://dtb.bmj.com/content/55/10/117) and discuss the use of the live attenuated influenza vaccine for children (http://dtb.bmj.com/content/55/10/114).

Duration: 00:12:10


September 2017: Vitamin D and adolescents: a forgotten ‘at risk’ group?

9/4/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss vitamin D deficiency in teenagers and highlight the challenge of implementing national recommendations on vitamin D intake in young people. Full article here: http://dtb.bmj.com/content/55/9/1. The editors also review the management of scarlet fever (http://dtb.bmj.com/content/55/9/102.2) and consider two drugs (baricitinib and tofacitinib) recently licensed for the management of...

Duration: 00:11:18


August 2017: What price drugs online?

7/26/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the supply of medicines from online primary care services (article here: http://dtb.bmj.com/content/55/8/85). The editors also review two recently licensed drugs: eluxadoline, a mixed opioid receptor agonist/antagonist for irritable bowel syndrome (http://dtb.bmj.com/content/55/8/90) and an oral formulation of glycopyrronium (http://dtb.bmj.com/content/55/8/93) for severe drooling...

Duration: 00:12:00


July 2017: The good, the bad and the ugly

7/5/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the role of Electroconvulsive Therapy (ECT) in the management of psychiatric disorders. Article accesible here: http://dtb.bmj.com/content/55/7/1. The editors also discuss the use of liraglutide for obesity (related article here: http://dtb.bmj.com/content/55/7/78)and highlight some of the challenges associated with the management of people with clinical features of both asthma and...

Duration: 00:13:36


June 2017: Turning the tide of high-dose inhaled corticosteroids

6/5/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of high-dose inhaled corticosteroids in asthma and COPD. The editors also highlight some of the challenges associated with the management of superficial venous thrombosis of the leg and discuss the use of carbohydrate deficient transferrin as a biomarker for the assessment of chronic alcohol use. Read more about the DTB's June 2017 issue:...

Duration: 00:11:16


May 2017: Rational rationing in the NHS?

5/3/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss attempts by the NHS in England to target £400m of prescribing expenditure that is reported to be wasted on a range of products that are considered to be of low value. Editorial available here: http://dtb.bmj.com/content/55/5/49 The editors also review the evidence for the use of off-label testosterone supplementation in menopausal women (http://dtb.bmj.com/content/55/5/57) and...

Duration: 00:13:02


March 2017: Better PrEParation needed?

3/14/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss some of the implications related to funding of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). They consider the Court of Appeal decision on funding and the role of clinical and health economic evaluations for preventative treatments. Full article available here: http://dtb.bmj.com/content/55/3/25. The editors also review the evidence for a new formulation of...

Duration: 00:12:57


February 2017: Spironolactone - potion or poison?

2/6/2017
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the risk of hyperkalaemia associated with spironolactone in people with heart failure. They consider recent advice issued by the Medicines and Healthcare products Regulatory Agency and highlight the importance of regular monitoring of potassium and renal function. The editors also review the evidence for daclizumab, a drug for relapsing multiple sclerosis, and provide a brief...

Duration: 00:14:31


November 2016: Rubella immunisation. Check vaccination history

11/7/2016
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss changes to the rubella screening programme and the need to ensure that MMR vaccinations are up to date, especially in younger women born outside the UK. Read the full editorial here: http://dtb.bmj.com/content/54/11/121.full. The editors also discuss prescribing information sources (http://dtb.bmj.com/content/54/11/129.full) and the evidence on the management of difficult to treat...

Duration: 00:11:18


October 2016: the dangers of a quicker authorisation process for drugs

10/21/2016
More
Why should we worry about the new European Medicines Agency (EMA) pilot project to accelerate the approval of new drugs? James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the October issue Editorial, that looks at the pros and cons of this new trend both in the USA and Europe. Read the full article here: http://dtb.bmj.com/content/54/10/109.full. Also in this podcast: • the use of the new antibiotic Fosfomycin trometamol for the treatment of acute...

Duration: 00:09:15


August 2016: Better guidelines. Capsaicin for diabetic neuropathy. Excipients in medicines

8/8/2016
More
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the presentation of guidelines and ways of making them more accessible. Read the full editorial here: http://dtb.bmj.com/content/54/8/85.full There’s also an evaluation of the use of capsaicin for diabetic peripheral neuropathy. Article accessible here: http://dtb.bmj.com/content/54/8/90.full The DTB editors also talk about medicines, excipients and dietary intolerances. Article...

Duration: 00:18:05


July 2016: Where next for rationing medicines? Vitamins during pregnancy: a big marketing campaign?

7/7/2016
More
In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss proposals to stop the prescription of some medicines and foods in order to help manage the deficit in NHS budgets. Full article available here: http://dtb.bmj.com/content/early/2016/07/07/dtb.2016.7.0409.full. The podcast also includes a review of an article about the effects of the antidiabetic drug empagliflozin on cardiovascular outcomes, as well as a review of an article on the use of...

Duration: 00:15:43